Nanomedicines for immunization and vaccines

• Tipo: Capítulo ou Parte de Livro
• Data: 2012

Autores

Fangueiro, JF (Autor) Outra; Severino, P (Autor) Outra; Souto, SB (Autor) Outra; Souto, EB (Autor) Outra

Livro

Título: Patenting Nanomedicines: Legal Aspects, Intellectual Property and Grant Opportunities

Páginas: 435-450

ISBN: 9783642292651; 364229264X; 9783642292644

Editora: Springer Berlin Heidelberg

Indexação

Scopus - 0 Citações

Outras Informações

ID Authenticus: P-00K-1TW

DOI: 10.1007/978-3-642-29265-1_15

Abstract (EN): Immunization and treatment of infectious diseases is been extensively exploited to develop better and safe vaccines. The efforts have been made to improve the effectiveness of vaccines and for this reason nanomedicine emerges as the ultimate alternative. Most common infectious diseases, such as hepatite B virus (HBV), human immunodeficiency virus/ acquired immune deficiency syndrome (HIV/AIDS) malaria, human papillomavirus (HPV) and tuberculosis (TB), have aggressive and prolonged treatments, and for this purpose the development of novel therapeutic systems is a priority aiming at reducing cytotoxicity and drug resistance. Examples of these novel systems are solid lipid nanoparticles (SLN), polymeric, inorganic, metallic, magnetic, viral-based nanoparticles and dendrimers that have been received more attention for their proven efficiency in providing immunization, targeting and triggering antibody response at the cellular level. This review focuses on the efforts that have been made towards the development of novel approaches and also patented and marketed formulations of nanocarrier-based vaccine formulations. © 2012 Springer-Verlag Berlin Heidelberg. All rights are reserved.

Idioma: Inglês

Tipo (Avaliação Docente): Científica